ArticlePediatric research2026
Topical glyceryl trinitrate for increasing radial arterial diameter in neonates: a randomised controlled trial.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWe evaluated the efficacy of topical Glyceryl trinitrate (GTN) in increasing the radial artery diameter (RAD) in neonates.
methodsThis single-centre randomised controlled trial was conducted in the tertiary neonatal intensive care unit (NICU) in Western Australia from August 2023 to July 2024. Hemodynamically stable neonates (gestation >34 weeks) admitted to the NICU were included. Neonates were randomised to GTN patch application for 30 min or 45 min or 60 min or placebo group. Primary outcome was change in ipsilateral RAD from baseline to post-intervention. Secondary outcomes were the absolute and percentage change from baseline in RAD in both limbs and safety (hypotension and methemoglobinemia).
resultsMean RAD at baseline in ipsilateral limb in the anteroposterior view (AP) was [0.87 (SD 0.09), 0.89 (0.14), 0.86 (0.11) and 0.86 (0.12) mm, respectively,in the placebo, 30 min, 45 min and 60 min GTN groups; p value on ANOVA = 0.80]. Post-intervention, there was notable increase in AP-RAD in all the three GTN patch groups [1.20 (0.17), 1.16 (0.15), 1.16 (0.15)] Vs 0.93 (0.11) in placebo (p value < 0.001). Similar increase in RAD was noted in the transverse view at 30, 45 and 60 minutes. Post-GTN RAD did not increase with longer duration of application (p > 0.5). Post-intervention, there were no statistically significant differences between the groups in heart rate, blood pressure, oxygen saturation and methaemoglobin levels.
conclusionTopical application of GTN increased RAD without clinically significant hypotension and methemoglobinemia in stable neonates. However, potential systemic effects warrant caution and further evaluation in critically ill infants.
trial registrationanzctr.org.au Identifier ACTRN 12623000509662p. IMPACT: First RCT in neonates evaluating the effect of topical glyceryl trinitrate (GTN) patch on radial artery diameter (RAD). Topical GTN increases RAD on both sides. Systemic side effects of topical GTN require careful monitoring in sick neonates. These findings provide a framework for future trials evaluating the impact of topical GTN on arterial cannulation success rates, and radial artery spasm.
Identifiers
42215663What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.